Impact of renal dysfunction on the management and outcome of acute heart failure: results from the French prospective, multicentre, DeFSSICA survey
- PMID: 30782685
- PMCID: PMC6340446
- DOI: 10.1136/bmjopen-2018-022776
Impact of renal dysfunction on the management and outcome of acute heart failure: results from the French prospective, multicentre, DeFSSICA survey
Abstract
Objectives: Cardiorenal syndrome (CRS) is the combination of acute heart failure syndrome (AHF) and renal dysfunction (creatinine clearance (CrCl) ≤60 mL/min). Real-life data were used to compare the management and outcome of AHF with and without renal dysfunction.
Design: Prospective, multicentre.
Setting: Twenty-six academic, community and regional hospitals in France.
Participants: 507 patients with AHF were assessed in two groups according to renal function: group 1 (patients with CRS (CrCl ≤60 mL/min): n=335) and group 2 (patients with AHF with normal renal function (CrCl >60 mL/min): n=172).
Results: Differences were observed (group 1 vs group 2) at admission for the incidence of chronic heart failure (56.42% vs 47.67%), use of furosemide (60.9% vs 52.91%), insulin (15.52% vs 9.3%) and amiodarone (14.33% vs 4.65%); additionally, more patients in group 1 carried a defibrillator (4.78% vs 0%), had ≥2 hospitalisations in the last year (15.52% vs 5.81%) and were under the care of a cardiologist (72.24% vs 61.63%). Clinical signs were broadly similar in each group. Brain-type natriuretic peptide (BNP) and BNP prohormone were higher in group 1 than group 2 (1157.5 vs 534 ng/L and 5120 vs 2513 ng/mL), and more patients in group 1 were positive for troponin (58.2% vs 44.19%), had cardiomegaly (51.04% vs 37.21%) and interstitial opacities (60.3% vs 47.67%). The only difference in emergency treatment was the use of nitrates, (higher in group 1 (21.9% vs 12.21%)). In-hospital mortality and the percentage of patients still hospitalised after 30 days were similar between groups, but the median stay was longer in group 1 (8 days vs 6 days).
Conclusions: Renal impairment in AHF should not limit the use of loop diuretics and/or vasodilators, but early assessment of pulmonary congestion and close monitoring of the efficacy of conventional therapies is encouraged to allow rapid and appropriate implementation of alternative therapies if necessary.
Keywords: acute heart Failure; ahf; cardio-renal syndrome; crs; real-life; renal dysfunction.
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: CEK has received grants from Novartis (other than this work), Daiichy Sankyo and Boehringer Ingleheim. NP report has acted as a paid consultant for Vygon SA. SC reports personal fees from Novartis (other than this work). LF is an employee of RESCUe Network.
Figures
Similar articles
-
Renal function on admission modifies prognostic impact of diuretics in acute heart failure: a propensity score matched and interaction analysis.Heart Vessels. 2016 Dec;31(12):1980-1987. doi: 10.1007/s00380-016-0817-y. Epub 2016 Feb 18. Heart Vessels. 2016. PMID: 26892531
-
Management of suspected acute heart failure dyspnea in the emergency department: results from the French prospective multicenter DeFSSICA survey.Scand J Trauma Resusc Emerg Med. 2016 Sep 17;24(1):112. doi: 10.1186/s13049-016-0300-x. Scand J Trauma Resusc Emerg Med. 2016. PMID: 27639971 Free PMC article.
-
Time-to-Furosemide Treatment and Mortality in Patients Hospitalized With Acute Heart Failure.J Am Coll Cardiol. 2017 Jun 27;69(25):3042-3051. doi: 10.1016/j.jacc.2017.04.042. J Am Coll Cardiol. 2017. PMID: 28641794
-
Decongestive treatment of acute decompensated heart failure: cardiorenal implications of ultrafiltration and diuretics.Am J Kidney Dis. 2011 Dec;58(6):1005-17. doi: 10.1053/j.ajkd.2011.07.023. Epub 2011 Oct 19. Am J Kidney Dis. 2011. PMID: 22014726 Review.
-
Renal dysfunction in acute congestive heart failure: a common problem for cardiologists and nephrologists.Heart Fail Rev. 2014 Nov;19(6):699-708. doi: 10.1007/s10741-013-9416-5. Heart Fail Rev. 2014. PMID: 24297366 Review.
Cited by
-
BNP as a Major Player in the Heart-Kidney Connection.Int J Mol Sci. 2019 Jul 22;20(14):3581. doi: 10.3390/ijms20143581. Int J Mol Sci. 2019. PMID: 31336656 Free PMC article. Review.
-
Irreversible oxidative post-translational modifications in heart disease.Expert Rev Proteomics. 2019 Aug;16(8):681-693. doi: 10.1080/14789450.2019.1645602. Epub 2019 Jul 30. Expert Rev Proteomics. 2019. PMID: 31361162 Free PMC article. Review.
-
Plasma thrombomodulin levels are associated with acute kidney injury in patients with acute heart failure.Ann Med. 2022 Dec;54(1):3169-3176. doi: 10.1080/07853890.2022.2142660. Ann Med. 2022. PMID: 36354140 Free PMC article.
-
Natriuretic Peptides in the Cardiovascular System: Multifaceted Roles in Physiology, Pathology and Therapeutics.Int J Mol Sci. 2019 Aug 16;20(16):3991. doi: 10.3390/ijms20163991. Int J Mol Sci. 2019. PMID: 31426320 Free PMC article.
-
A Combination of Chest Radiography and Estimated Plasma Volume May Predict In-Hospital Mortality in Acute Heart Failure.Front Cardiovasc Med. 2022 Jan 11;8:752915. doi: 10.3389/fcvm.2021.752915. eCollection 2021. Front Cardiovasc Med. 2022. PMID: 35087878 Free PMC article.
References
-
- Ferreira JP, Girerd N, Pellicori P, et al. . Renal function estimation and Cockroft-Gault formulas for predicting cardiovascular mortality in population-based, cardiovascular risk, heart failure and post-myocardial infarction cohorts: The Heart ‘OMics’ in AGEing (HOMAGE) and the high-risk myocardial infarction database initiatives. BMC Med 2016;14:181 10.1186/s12916-016-0731-2 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous